Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/24/2025

Treatment and Prevention of Ephelides in Fitzpatrick Type 1 Skin

Introduction to Ephelides

  • Fitzpatrick type 1 skin has minimal melanin content and is highly susceptible to UV damage, making sun protection particularly crucial 1

Prevention Strategies

  • Daily application of broad-spectrum sunscreen (minimum SPF 30) containing zinc oxide or titanium dioxide is essential for preventing new ephelides and darkening of existing ones 2, 3
  • Sunscreen should be applied to all exposed skin areas regardless of season 3
  • Physical sun avoidance is strongly recommended, including staying out of direct sunlight when possible 3
  • Protective clothing and wide-brimmed hats provide additional protection 2, 3
  • Use of gentle, pH-neutral cleansers to avoid skin irritation that could trigger post-inflammatory hyperpigmentation 3
  • Avoid manipulation of skin and harsh physical treatments that could cause irritation 3
  • Moisturize skin regularly with hypoallergenic, non-greasy products to maintain skin barrier function 3

Special Considerations

  • Individuals with Fitzpatrick type 1 skin require lower starting doses for any phototherapy treatment (0.5 J/cm² for UVA) with smaller incremental increases (0.5 J/cm²) 4, 5, 6
  • These patients burn easily with minimal sun exposure, making them more susceptible to photosensitivity reactions 7
  • Careful monitoring for erythema and other adverse reactions is essential during any treatment 4

Treatment Algorithm

  • First-line treatment includes sun protection and topical agents, with daily broad-spectrum sunscreen (SPF 30+) 2, 3
  • Reinforce sun protection measures at every visit to prevent ephelides and promote overall skin health 2, 3
  • Avoid aggressive treatments that can cause irritation and lead to post-inflammatory hyperpigmentation 3
  • Never use photosensitizing medications concurrently with light-based treatments 7